FR Pharma Consulting ApS: Financial statements 2024
CVR: 44253569
Source: annual report 2024, Danish Business Authority
23/08/2023 – 30/06/2024
FR Pharma Consulting ApS (CVR 44253569) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 750,076 and a net result of DKK 203,351. Equity in the 2024 report amounted to DKK 243,351. The solvency ratio was 56.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 750,076
- Profit/Loss
- DKK 203,351
- Equity
- DKK 243,351
- Total Assets
- DKK 432,643
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
FR Pharma Consulting ApS has published its interim report for the period August 23, 2023 to June 30, 2024.
About FR Pharma Consulting ApS
FR Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2023. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Ferhat Celik. The company is owned by FR Pharma ApS. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK 424,639 and a net result of DKK -336,968 compared with DKK 654,878 the year before. Equity in the 2026 report amounted to DKK 561,263.